|
IPSC | Century Therapeutics, Inc. |
|
|
IPSC | Century Therapeutics, Inc. |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ 1.76 |
| Leverage | 27.94% |
| Market Cap | $ 99.9m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -26.0m |
| Margin | -22.93% |
None